Clinical Trial Update: Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial update assessing muraglitazar for Type 2 diabetes, focusing on mechanism of action and efficacy; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Muraglitazar (muraglitazar)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED